Exclusive
FDA-iRISK (Journal of Food Protection)
A Comparative Risk Assessment System for Evaluating and Ranking Food-Hazard Pairs: Case Studies on Microbial Hazards
PUBLISHED ON Jan 1, 2013
LAST UPDATED Jan 1, 2013
ACCESS TYPEOpen
Related Resources

Associated Tools

FDA-iRISKĀ® 4.2

Metadata Updated: November 15, 2017

Journal of Food Protection, Vol. 76, No. 3, 2013, Pages 376–385, doi:10.4315/0362-028X.JFP-12-372

YUHUAN CHEN,1 SHERRI B. DENNIS,1* EMMA HARTNETT,2 GREG PAOLI,RÉGIS POUILLOT,1 TODD RUTHMAN,2 AND MARGARET WILSON 2

U.S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, 5100 Paint Branch Parkway, College Park, Maryland 20740, USA; and 
Risk Sciences International, Inc., 325 Dalhousie Street, Ottawa, Ontario, Canada K1N 7G2

ABSTRACT

Stakeholders in the system of food safety, in particular federal agencies, need evidence-based, transparent, and rigorous approaches to estimate and compare the risk of foodborne illness from microbial and chemical hazards and the public health impact of interventions. FDA-iRISK (referred to here as iRISK), a Web-based quantitative risk assessment system, was developed to meet this need. The modeling tool enables users to assess, compare, and rank the risks posed by multiple food-hazard pairs at all stages of the food supply system, from primary production, through manufacturing and processing, to retail distribution and, ultimately, to the consumer. Using standard data entry templates, built-in mathematical functions, and Monte Carlo simulation techniques, iRISK integrates data and assumptions from seven components: the food, the hazard, the population of consumers, process models describing the introduction and fate of the hazard up to the point of consumption, consumption patterns, dose-response curves, and health effects. Beyond risk ranking, iRISK enables users to estimate and compare the impact of interventions and control measures on public health risk. iRISK provides estimates of the impact of proposed interventions in various ways, including changes in the mean risk of illness and burden of disease metrics, such as losses in disability-adjusted life years. Case studies for Listeria monocytogenes and Salmonella were developed to demonstrate the application of iRISK for the estimation of risks and the impact of interventions for microbial hazards. iRISK was made available to the public at irisk.foodrisk.org in October 2012.

Supplemental Materials

Supplemental Tables: https://irisk.foodrisk.org/Documents/JFP12_372_SupplTables.pdf

FDA-iRISK, v 1.0, Technical documentation: http://irisk.foodrisk.org/SupportingDocumentation.aspx